FGF19 | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

25 results for “FGF19”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

FGF19 and the Expression of IRS-1 and GLUT-1 in Gestational Diabetes Mellitus

36 participants · First posted Jan 25, 2019

Tumor-Derived FGF19

119 participants · First posted Oct 5, 2023

FGF19 and Chronic Kidney Disease

170 participants · First posted May 21, 2021

FGF19 in Obstructive Cholestasis: "Unveil the Signal"

81 participants · First posted Feb 8, 2023

Not yet recruiting

Relationship Between FGF19 Overexpression and Disease Prognosis

100 participants · First posted Apr 22, 2025

FGF19 Overexpression Combination Unified Study in HCC-19

42 participants · First posted May 18, 2025

Preoperative Serum FGF19 in the Prognosis of Biliary Atresia

200 participants · First posted May 8, 2023

Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea

71 participants · First posted Feb 23, 2017

ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression

141 participants · First posted Jan 8, 2026

Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer

14 participants · First posted Apr 2, 2021

Page 1 of 2